HK1086331A1 - Compounds and methods for detection of carcinomas and their precursor lesions - Google Patents
Compounds and methods for detection of carcinomas and their precursor lesionsInfo
- Publication number
- HK1086331A1 HK1086331A1 HK06106080.2A HK06106080A HK1086331A1 HK 1086331 A1 HK1086331 A1 HK 1086331A1 HK 06106080 A HK06106080 A HK 06106080A HK 1086331 A1 HK1086331 A1 HK 1086331A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- carcinomas
- detection
- precursor lesions
- methods
- compounds
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
- G01N2333/922—Ribonucleases (RNAses); Deoxyribonucleases (DNAses)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02102814A EP1431762B1 (en) | 2002-12-18 | 2002-12-18 | Compounds and methods for detection of carcinomas and their precursor lesions |
PCT/EP2003/051028 WO2004055514A1 (en) | 2002-12-18 | 2003-12-16 | Compounds and methods for detection of carcinomas and their precursor lesions |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1086331A1 true HK1086331A1 (en) | 2006-09-15 |
Family
ID=32338157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06106080.2A HK1086331A1 (en) | 2002-12-18 | 2006-05-26 | Compounds and methods for detection of carcinomas and their precursor lesions |
Country Status (11)
Country | Link |
---|---|
US (2) | US20060121485A1 (ja) |
EP (1) | EP1431762B1 (ja) |
JP (1) | JP4527544B2 (ja) |
CN (1) | CN1726393B (ja) |
AT (1) | ATE360817T1 (ja) |
AU (1) | AU2003302964A1 (ja) |
CA (1) | CA2510150C (ja) |
DE (1) | DE60219809T2 (ja) |
ES (1) | ES2286201T3 (ja) |
HK (1) | HK1086331A1 (ja) |
WO (1) | WO2004055514A1 (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60219809T2 (de) * | 2002-12-18 | 2008-01-17 | Coy, Johannes F., Dr. | Verbindungen und Verfahren zur Nachweiss von Karzinomen und deren Vorstufen |
US8710012B2 (en) * | 2003-07-14 | 2014-04-29 | Cls Therapeutics Limited | Method for treating oncological diseases |
US8388951B2 (en) | 2003-07-14 | 2013-03-05 | Cls Therapeutics Limited | Method for treating systemic DNA mutation disease |
BRPI0717439A2 (pt) * | 2006-10-18 | 2013-11-19 | Periness Ltd | Composição farmacêutica, e, métodos para tratar subfertilidade masculina, para determinar um estado de fertlidade em um indivíduo do sexo masculino, para a reprodução assistida, para selecionar uma técnica de reprodução assistida e para selecionar células de esperma em uma população de células de esperma para uso em uma técnica de reprodução auxiliada. |
JP2008253188A (ja) * | 2007-04-04 | 2008-10-23 | Tokyo Univ Of Science | エンドサイトーシス依存性dna取り込み抑制剤、エンドサイトーシス依存性dna取り込み促進剤、ウイルス感染阻害剤、ウイルス感染予防剤、及びウイルス感染促進剤、並びに、遺伝子マーカー、モノクローナル抗体、ハイブリドーマ、及びそれらの使用方法。 |
US7734161B2 (en) * | 2007-04-19 | 2010-06-08 | Avago Technologies Ecbu Ip (Singapore) Pte. Ltd. | Image stabilization with adaptive shutter control |
US9360489B2 (en) * | 2007-06-11 | 2016-06-07 | Sutter Bay Hospitals | Method and kit for dynamic gene expression monitoring |
US10617743B2 (en) | 2014-06-19 | 2020-04-14 | Cls Therapeutics Limited | Method to improve safety and efficacy of anti-cancer therapy |
CN104267011A (zh) * | 2014-09-23 | 2015-01-07 | 中国科学院东北地理与农业生态研究所 | 一种转基因羊卵母细胞的筛选方法 |
CN108289932A (zh) | 2015-05-22 | 2018-07-17 | D·D·格恩金 | 胞外dna作为神经变性的治疗靶点 |
CN107677822A (zh) * | 2016-08-02 | 2018-02-09 | 北京金沐医疗科技有限公司 | 检测肿瘤标志物的荧光细胞计数检测试剂盒 |
CN107677823A (zh) * | 2016-08-02 | 2018-02-09 | 北京金沐医疗科技有限公司 | 一种用于检测肿瘤抗原的蛋白芯片试剂盒及其检测方法 |
CN107677820A (zh) * | 2016-08-02 | 2018-02-09 | 北京金沐医疗科技有限公司 | 一种检测肿瘤抗原的试剂盒及其检测方法 |
CN112292453A (zh) | 2018-01-16 | 2021-01-29 | Cls治疗有限公司 | 通过肝脏表达具有脱氧核糖核酸酶(dna酶)活性的酶治疗疾病 |
CN109406771B (zh) * | 2018-10-26 | 2023-04-07 | 安徽大千生物工程有限公司 | 胱抑素c胶乳增强比浊法检测试剂盒及其制备使用方法 |
CN113314220B (zh) * | 2021-07-28 | 2021-11-02 | 江苏为真生物医药技术股份有限公司 | 疾病病程监控系统、计算机可读存储介质以及电子设备 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19521046C1 (de) * | 1995-06-09 | 1996-08-08 | Deutsches Krebsforsch | Protein mit DNase-Aktivität |
WO2000052204A2 (en) * | 1999-02-22 | 2000-09-08 | Orntoft Torben F | Gene expression in bladder tumors |
US20020052308A1 (en) * | 1999-03-12 | 2002-05-02 | Rosen Craig A. | Nucleic acids, proteins and antibodies |
EP1249495A1 (de) * | 2001-04-11 | 2002-10-16 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Murine DNase X, diese enthaltendes Arzneimittel und nicht-menschliches Säugetier mit verändertem DNase X-Gen |
CA2466483A1 (en) * | 2001-11-07 | 2003-07-03 | John D. Shaughnessy | Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
AU2002349786A1 (en) * | 2002-06-19 | 2004-01-06 | Japan As Represented By The President Of The University Of Tokyo | Method for diagnosis of colorectal tumors |
DE60219809T2 (de) * | 2002-12-18 | 2008-01-17 | Coy, Johannes F., Dr. | Verbindungen und Verfahren zur Nachweiss von Karzinomen und deren Vorstufen |
-
2002
- 2002-12-18 DE DE60219809T patent/DE60219809T2/de not_active Expired - Lifetime
- 2002-12-18 EP EP02102814A patent/EP1431762B1/en not_active Expired - Lifetime
- 2002-12-18 AT AT02102814T patent/ATE360817T1/de active
- 2002-12-18 ES ES02102814T patent/ES2286201T3/es not_active Expired - Lifetime
-
2003
- 2003-12-16 WO PCT/EP2003/051028 patent/WO2004055514A1/en active Application Filing
- 2003-12-16 US US10/539,233 patent/US20060121485A1/en not_active Abandoned
- 2003-12-16 JP JP2004560521A patent/JP4527544B2/ja not_active Expired - Lifetime
- 2003-12-16 CN CN2003801065094A patent/CN1726393B/zh not_active Expired - Fee Related
- 2003-12-16 CA CA2510150A patent/CA2510150C/en not_active Expired - Lifetime
- 2003-12-16 AU AU2003302964A patent/AU2003302964A1/en not_active Abandoned
-
2006
- 2006-05-26 HK HK06106080.2A patent/HK1086331A1/xx not_active IP Right Cessation
-
2007
- 2007-10-29 US US11/927,274 patent/US8759004B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20080234393A1 (en) | 2008-09-25 |
CA2510150C (en) | 2017-11-07 |
US8759004B2 (en) | 2014-06-24 |
EP1431762A1 (en) | 2004-06-23 |
ATE360817T1 (de) | 2007-05-15 |
ES2286201T3 (es) | 2007-12-01 |
DE60219809D1 (de) | 2007-06-06 |
CN1726393B (zh) | 2010-04-28 |
JP2006510363A (ja) | 2006-03-30 |
WO2004055514A1 (en) | 2004-07-01 |
EP1431762B1 (en) | 2007-04-25 |
CA2510150A1 (en) | 2004-07-01 |
AU2003302964A1 (en) | 2004-07-09 |
CN1726393A (zh) | 2006-01-25 |
DE60219809T2 (de) | 2008-01-17 |
JP4527544B2 (ja) | 2010-08-18 |
US20060121485A1 (en) | 2006-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1086331A1 (en) | Compounds and methods for detection of carcinomas and their precursor lesions | |
WO2006128192A3 (en) | Use of free circulating dna for diagnosis, prognosis, and treatment of cancer | |
WO2001018252A3 (en) | Methods for disease detection | |
CA2421007A1 (en) | Method for detection of htr and htert telomerase-associated rna in plasma or serum | |
WO2001042502A3 (en) | Methods for disease detection | |
EP2330219A3 (en) | Method for drug discovery, disease treatment and diagnosis using metabolomics | |
WO2002086448A3 (en) | Detection of microsatellite instability and its use in diagnosis of tumors | |
WO2006113747A3 (en) | Diagnostic markers of breast cancer treatment and progression and methods of use thereof | |
ATE275642T1 (de) | Verfahren zur diagnose von krebs | |
WO2005040421A3 (en) | Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues | |
JP2006506979A5 (ja) | ||
WO2003007803A3 (en) | Methods for diagnosing and treating alzheimer's disease and parkinson's disease | |
WO2006081248A3 (en) | Cancer markers and detection methods | |
DE602006012995D1 (de) | Brustkrebsdiagnoseverfahren | |
DE60137264D1 (de) | Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc) | |
WO2004029285A3 (en) | Methods for detecting endocrine cancer | |
DE60325382D1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
WO2007020522A3 (en) | Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type | |
CA2531451A1 (en) | Methods and nucleic acids for analyses of colorectal cell proliferative disorders | |
DE60331857D1 (de) | Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit | |
WO2004109286A3 (en) | Methods for detecting and treating cancer using podocalyxin and/or endoglycan | |
ATE376595T1 (de) | Nachweisverfahren mit biochip | |
WO2005001140A3 (en) | Methods and nucleic acids for the analysis of colon cell proliferative disorders | |
WO2006131677A3 (fr) | Procede pour le diagnostic/pronostic du cancer du sein | |
DE50105971D1 (de) | Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20131216 |